2025年2月5日，Dana-Farber 癌症研究所研究人员在《Nature》发表了题为：A neoantigen vaccine generates antitumour immunity in renal cell ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

在肾细胞癌的辅助治疗中，一项 3 期临床试验显示，使用帕博利珠单抗的患者无病生存期和总生存期均有所改善；然而，许多患者仍出现疾病复发。此外，另外三项关于免疫检查点抑制剂（包括阿特珠单抗、纳武单抗以及纳武单抗联合伊匹单抗）的辅助治疗和围手术期的 3 ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...

研究结果表明，在高危肾细胞癌中，针对新抗原的个性化癌症疫苗具有高度免疫原性，能够靶向关键的癌症驱动突变，并能 ...